fashion -WSS

fashion

author：Wikipedia 2025-08-23 05:00:45 - browse：89454

President Joe Biden speaks and gestures at a podium outdoor — In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors. MANDEL NGAN/AFP via Getty Images

WASHINGTON — The Biden administration announced Tuesday that it’s raising taxes on a range of imported products from China, including syringes, needles, and surgical gloves.

Pitched as a plan to support American workers, the tariffs are meant to protect domestic manufacturers from China’s “unfair trade practices” and “artificially low-priced exports.” In addition to medical devices, the United States will raise tariffs on $18 billion worth of products including electric vehicles, batteries, and semiconductors.

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

The inclusion of syringes comes after the Food and Drug Administration’s repeated warnings to U.S. medical providers about quality issues with plastic syringes from China. The agency first alerted consumers in November 2023 about leaks and breaks associated with Chinese syringes. In March, the FDA called attention to three warning letters it sent to firms in China for selling syringes that had not received FDA clearance. It has since sent a warning letter to Cardinal Health.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Future doctors need a strong humanities education

hotspot

focus

WSS

Maisha Meds is a PBM, but don't call it that

Biden praises World Series champion Astros for impact off the field during White House celebration

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Inaction leaves children at risk from dangerous chemotherapy drug

Maisha Meds is a PBM, but don't call it that

FDA sets aggressive timeline for overhauling inspection procedures

hotspot

fashion

Related: Drug supplies for millions would be jeopardized by U.S. crackdown on China biopharma industry, trade group says

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

knowledge

Hollywood unions extend contract negotiations for actors

Germany receives 178 compensation applications from gay servicepeople over discrimination

Affirmative action in medical school literally saved lives

Choosing scientific sides in the fight against Alzheimer's

Wildfire smoke exposes gaps in outdoor worker protections

The inclusion problem at the heart of rehabilitation research

At least 13 dead in Texas as scorching temps continue

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Affirmative action in medical school literally saved lives

There's an unseen cost to disruptive road

explore

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Maisha Meds is a PBM, but don't call it that

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Prior authorization reform is both possible and imperative

Mass General, Mayo Clinic look to monetize custom

CVS is on a mission to consolidate health care. Will it work?

hotspot

focus

entertainment

explore